Detalhe da pesquisa
1.
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Lancet
; 402(10409): 1272-1281, 2023 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708904
2.
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.
Liver Int
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588031
3.
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions.
Future Oncol
; 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348690
4.
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
Lancet Oncol
; 24(7): 772-782, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276871
5.
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
Oncologist
; 28(6): 553-e472, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940261
6.
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe.
BMC Cancer
; 23(1): 877, 2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723453
7.
Assessment of the level III of Inoue by preoperative endoscopic ultrasound and elastography: a novel approach to predict a periarterial divestment technique in borderline resectable (BR) or locally advanced (LA) pancreatic adenocarcinoma-How I do it.
Langenbecks Arch Surg
; 408(1): 367, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731066
8.
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
N Engl J Med
; 381(4): 317-327, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157963
9.
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study.
Qual Life Res
; 31(2): 473-485, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115280
10.
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.
Ann Surg Oncol
; 28(12): 7545-7554, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33813673
11.
Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): A post hoc analysis of NAPOLI-1.
Pancreatology
; 21(1): 192-199, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33214082
12.
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 21(6): 796-807, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416072
13.
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.
Br J Cancer
; 123(11): 1590-1598, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32913286
14.
A new targeted treatment for patients with a germline BRCA mutation: olaparib in pancreatic cancer.
Future Oncol
; 16(33): 2691-2700, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32799562
15.
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.
Future Oncol
; 16(30): 2385-2399, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32677452
16.
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial.
Future Oncol
; 16(30): 2375-2384, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580579
17.
Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.
BMC Palliat Care
; 19(1): 103, 2020 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32650765
18.
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors.
Invest New Drugs
; 37(4): 674-683, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411218
19.
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma.
Future Oncol
; 15(16): 1811-1822, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30969136
20.
CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine.
Future Oncol
; 15(12): 1295-1302, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768369